- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Annovis Bio Inc (ANVS)
Annovis Bio Inc stock price live, this page displays NYSE ANVS stock exchange data. View the ANVS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Annovis Bio Inc real time stock price chart below.
What Is the Annovis Bio Inc Stock Price Today?
The Annovis Bio Inc stock price today is 1.76.
What Is the Stock Symbol for Annovis Bio Inc?
The stock ticker symbol for Annovis Bio Inc is ANVS.
Is ANVS the Same as $ANVS?
$ANVS is a common way to refer to the Annovis Bio Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Annovis Bio Inc Trade On?
Annovis Bio Inc is listed and trades on the NYSE stock exchange.
Is Annovis Bio Inc a Good Stock to Buy?
Determining whether Annovis Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Annovis Bio Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANVS quote. (ISIN: US03615A1088)
What Is the Annovis Bio Inc Stock Price Today?
The Annovis Bio Inc stock price today is 1.76.
What Is the Stock Symbol for Annovis Bio Inc?
The stock ticker symbol for Annovis Bio Inc is ANVS.
Is ANVS the Same as $ANVS?
$ANVS is a common way to refer to the Annovis Bio Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Annovis Bio Inc Trade On?
Annovis Bio Inc is listed and trades on the NYSE stock exchange.
Is Annovis Bio Inc a Good Stock to Buy?
Determining whether Annovis Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Annovis Bio Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANVS quote. (ISIN: US03615A1088)
1.77
+0.04(+2.02%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.71
1.78
52 wk Range
1.19
5.50
ANVS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.711.78
52 wk Range
1.195.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ANVS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
12.50
Upside
+606.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company’s lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer’s disease, as well as in phase 3 to treat parkinson’s disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer’s disease and dementia. Annovis Bio, Inc. was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.
Compare ANVS to Peers and Sector
Metrics to compare | ANVS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANVSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.1x | −3.4x | −0.5x | |
PEG Ratio | −0.05 | 0.11 | 0.00 | |
Price / Book | 3.5x | 6.3x | 2.6x | |
Price / LTM Sales | - | 10.3x | 3.2x | |
Upside (Analyst Target) | - | 91.9% | 47.6% | |
Fair Value Upside | Unlock | 3.5% | 6.1% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 12.50
(+606.21% Upside)
Earnings
Latest Release
Apr 06, 2026
EPS / Forecast
-0.39 / -0.34
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Annovis Bio (ANVS) Stock Price Today?
The Annovis Bio stock price today is 1.77 USD.
What Stock Exchange Does Annovis Bio Trade On?
Annovis Bio is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Annovis Bio?
The stock symbol for Annovis Bio is "ANVS."
What Is the Annovis Bio Market Cap?
As of today, Annovis Bio market cap is 61.12M USD.
What Is Annovis Bio's Earnings Per Share (TTM)?
The Annovis Bio EPS (TTM) is -1.40.
When Is the Next Annovis Bio Earnings Date?
Annovis Bio will release its next earnings report on May 19, 2026.
From a Technical Analysis Perspective, Is ANVS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Annovis Bio Stock Split?
Annovis Bio has split 0 times.
How Many Employees Does Annovis Bio Have?
Annovis Bio has 7 employees.
What is the current trading status of Annovis Bio (ANVS)?
As of Apr 15, 2026, Annovis Bio (ANVS) is trading at a price of 1.77 USD, with a previous close of 1.73 USD. The stock has fluctuated within a day range of 1.71 USD to 1.78 USD, while its 52-week range spans from 1.19 USD to 5.50 USD.
What Is Annovis Bio (ANVS) Price Target According to Analysts?
The average 12-month price target for Annovis Bio is 12.50 USD, with a high estimate of 17 USD and a low estimate of 8 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +606.21% Upside potential.
What Is the ANVS Premarket Price?
ANVS's last pre-market stock price is 1.75 USD. The pre-market share volume is 7,990.00, and the stock has decreased by 0.02, or 1.16%.
What Is the ANVS After Hours Price?
ANVS's last after hours stock price is 1.72 USD, the stock has decreased by -0.01, or -0.58%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.